PA143049

Factor XII Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PA143049-Each-of-1 In Stock ₹ 29,147.50

PA143049 - Each of 1

₹ 29,147.50

In Stock

Quantity

1

Base Price: ₹ 29,147.50

GST (18%): ₹ 5,246.55

Total Price: ₹ 34,394.05

Antigen

Factor XII

Classification

Polyclonal

Conjugate

Unconjugated

Gene

F12

Gene Alias

beta-factor XIIa part 1; Beta-factor XIIa part 2; coagulation factor XII; coagulation factor XII (Hageman factor); coagulation factor XIIa heavy chain; Coagulation factor XIIa light chain; F12; F13; Factor 12; factor XII; Factor12; FXII; HAE3; HAEX; HAF; hageman factor

Host Species

Sheep

Purification Method

Ammonium sulfate precipitation, Ion-exchange chromatography

Regulatory Status

RUO

Gene ID (Entrez)

2161

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Applications

ELISA, Western Blot

Concentration

14.4 mg/mL

Formulation

50% water with 50% glycerol and no preservative

Gene Accession No.

P00748

Gene Symbols

F12

Immunogen

Human Factor XII.

Quantity

1 mg

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PA143048

--

Img

Thermo Scientific

PA143041

--

Img

Thermo Scientific

PA143043

--

Img

Thermo Scientific

PA143050

--

Img

Thermo Scientific

PA143039

--

Img

Thermo Scientific

PA143051

--

Img

Thermo Scientific

PA143064

--

Img

Thermo Scientific

FEPA5145205

--

Description

  • PA1-43049 detects Factor XII in human samples
  • PA1-43049 has successfully been used in Western blot and ELISA applications
  • PA1-43049 was derived from human factor XII
  • This single chain zymogen is converted to a two-chain serine protease with an heavy chain (alpha-factor XIIa) and a light chain
  • The heavy chain contains two fibronectin-type domains, two epidermal growth factor (EGF)-like domains, a kringle domain and a proline-rich domain, whereas the light chain contains only a catalytic domain
  • On activation, further cleavages takes place in the heavy chain, resulting in the production of beta-factor XIIa light chain and the alpha-factor XIIa light chain becomes beta-factor XIIa heavy chain
  • Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then to beta-factor XIIa
  • The active factor XIIa participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin
  • It activates coagulation factors VII and XI
  • Defects in this gene do not cause any clinical symptoms and the sole effect is that whole-blood clotting time is prolonged.